178 related articles for article (PubMed ID: 35652296)
1. Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children.
Guillot M; Synnes A; Pronovost E; Qureshi M; Daboval T; Caouette G; Olivier F; Bartholomew J; Mohamed I; Massé E; Afifi J; Hendson L; Lemyre B; Luu TM; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Ducruet T; Ndiaye ABKT; Angoa G; Sériès T; Piedboeuf B; Nuyt AM; Fraser W; Mâsse B; Lacaze-Masmonteil T; Lavoie PM; Marc I
Pediatrics; 2022 Jul; 150(1):. PubMed ID: 35652296
[TBL] [Abstract][Full Text] [Related]
2. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Collins CT; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Smithers LG; Willson K; Ryan P
JAMA; 2009 Jan; 301(2):175-82. PubMed ID: 19141765
[TBL] [Abstract][Full Text] [Related]
4. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
5. Effect of Maternal Docosahexaenoic Acid Supplementation on Very Preterm Infant Growth: Secondary Outcome of a Randomized Clinical Trial.
Angoa G; Pronovost E; Ndiaye ABKT; Lavoie PM; Lemyre B; Mohamed I; Simonyan D; Qureshi M; Afifi J; Yusuf K; Sériès T; Guillot M; Piedboeuf B; Fraser WD; Nuyt AM; Mâsse B; Lacaze-Masmonteil T; Marc I
Neonatology; 2022; 119(3):377-385. PubMed ID: 35413719
[TBL] [Abstract][Full Text] [Related]
6. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
[TBL] [Abstract][Full Text] [Related]
7. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Yelland L; Quinlivan J; Ryan P;
JAMA; 2010 Oct; 304(15):1675-83. PubMed ID: 20959577
[TBL] [Abstract][Full Text] [Related]
8. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial.
Andrew MJ; Parr JR; Montague-Johnson C; Laler K; Holmes J; Baker B; Sullivan PB
Dev Med Child Neurol; 2018 Sep; 60(9):897-905. PubMed ID: 29806081
[TBL] [Abstract][Full Text] [Related]
9. Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS).
Guillot M; Robitaille CA; Turner L; Pronovost E; Caouette G; Matte-Gagné C; Olivier F; Bartholomew J; Massé É; Morin A; Mohamed I; Marc I
BMJ Open; 2022 May; 12(5):e057482. PubMed ID: 35508343
[TBL] [Abstract][Full Text] [Related]
10. DHA supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial.
Hewawasam E; Collins CT; Muhlhausler BS; Yelland LN; Smithers LG; Colombo J; Makrides M; McPhee AJ; Gould JF
Br J Nutr; 2021 Feb; 125(4):420-431. PubMed ID: 32660658
[TBL] [Abstract][Full Text] [Related]
11. The impact of DocosaHexaenoic Acid supplementation during pregnancy and lactation on Neurodevelopment of the offspring in India (DHANI): trial protocol.
Khandelwal S; Swamy MK; Patil K; Kondal D; Chaudhry M; Gupta R; Divan G; Kamate M; Ramakrishnan L; Bellad MB; Gan A; Kodkany BS; Martorell R; Srinath Reddy K; Prabhakaran D; Ramakrishnan U; Tandon N; Stein AD
BMC Pediatr; 2018 Aug; 18(1):261. PubMed ID: 30077178
[TBL] [Abstract][Full Text] [Related]
12. Association of Histologic Chorioamnionitis With Perinatal Brain Injury and Early Childhood Neurodevelopmental Outcomes Among Preterm Neonates.
Bierstone D; Wagenaar N; Gano DL; Guo T; Georgio G; Groenendaal F; de Vries LS; Varghese J; Glass HC; Chung C; Terry J; Rijpert M; Grunau RE; Synnes A; Barkovich AJ; Ferriero DM; Benders M; Chau V; Miller SP
JAMA Pediatr; 2018 Jun; 172(6):534-541. PubMed ID: 29610829
[TBL] [Abstract][Full Text] [Related]
13. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.
Collins CT; Gibson RA; Anderson PJ; McPhee AJ; Sullivan TR; Gould JF; Ryan P; Doyle LW; Davis PG; McMichael JE; French NP; Colditz PB; Simmer K; Morris SA; Makrides M
BMJ Open; 2015 Mar; 5(3):e007314. PubMed ID: 25787990
[TBL] [Abstract][Full Text] [Related]
15. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.
Auestad N; Scott DT; Janowsky JS; Jacobsen C; Carroll RE; Montalto MB; Halter R; Qiu W; Jacobs JR; Connor WE; Connor SL; Taylor JA; Neuringer M; Fitzgerald KM; Hall RT
Pediatrics; 2003 Sep; 112(3 Pt 1):e177-83. PubMed ID: 12949309
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic Acid and Arachidonic Acid Supplementation and Sleep in Toddlers Born Preterm: Secondary Analysis of a Randomized Clinical Trial.
Boone KM; Rausch J; Pelak G; Li R; Turner AN; Klebanoff MA; Keim SA
J Clin Sleep Med; 2019 Sep; 15(9):1197-1208. PubMed ID: 31538590
[TBL] [Abstract][Full Text] [Related]
17. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng SM; Turner MA; Weindling AM
Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
[No Abstract] [Full Text] [Related]
19. Fatty Acid Supplementation and Socioemotional Outcomes: Secondary Analysis of a Randomized Trial.
Boone KM; Parrott A; Rausch J; Yeates KO; Klebanoff MA; Norris Turner A; Keim SA
Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32887793
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
